Terns Pharmaceuticals CEO bows out for health reasons

Terns Pharmaceuticals CEO Senthil Sundaram has resigned from his position for health reasons.

Senthil Sundaram

Terns disclosed in an SEC filing in January of last year that Sundaram had received a cancer diagnosis and would “undergo aggressive treatment, including chemotherapy.” At…
Click here to view original post